Alector Inc. (ALEC) NASDAQ

$6.13 0.05 (0.82%)

Market Cap: $582.16M

As of 03/28/24 11:51 AM EDT. Market open.

(ALEC)

Alector Inc. (ALEC)
NASDAQ

$6.13
0.05 (0.82%)

Market Cap: $582.16M

As of 03/28/24 11:51 AM EDT. Market open.

Add to Portfolio

we are a biotech company based in san francisco dedicated to the discovery and development of novel therapies harnessing the power of immune system to treat neurodegenerative diseases such as alzheimer's ... read more

we are a biotech company based in san francisco dedicated to the discovery and development of novel therapies harnessing the power of immune system to treat neurodegenerative diseases such as alzheimer's disease. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Arnon Rosenthal
Full Time Employees
294
CEO Compensation (Base)
$396,764
CEO Compensation (Total)
$5.45M
URL
Address
151 Oyster Point Blvd Ste 300, California, South San Francisco, 94080-1841.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Arnon Rosenthal
Full Time Employees
294
CEO Compensation (Base)
$396,764
CEO Compensation (Total)
$5.45M
Address
151 Oyster Point Blvd Ste 300, California, South San Francisco, 94080-1841.
PRICE CHART FOR ALECTOR INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$6.12
Previous Close
$6.08
Days Range
$5.93 - $6.16
52 week range
$3.66 - $9.07
Volume
55,693
Avg. Volume (30 days)
727,486
Market Cap
$582.16M
Dividend Yield
-
P/E
(4.46)
Shares Outstanding
95,749,259
Open
$6.12
Previous Close
$6.08
Days Range
$5.93 - $6.16
52 week range
$3.66 - $9.07
Volume
55,693
Avg. Volume (30 days)
727,486
Market Cap
$582.16M
Dividend Yield
-
P/E
(4.46)
Shares Outstanding
95,749,259
FINANCIAL STATEMENTS FOR ALECTOR INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ALECTOR INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
GRASSO MARCChief Financial OfficerDec 04, 2023 Sale$5.564,57425,431150,673Dec 06, 2023, 06:30 PM
Romano GaryChief Medical OfficerDec 04, 2023 Sale$5.565,03527,995202,314Dec 06, 2023, 06:30 PM
Rosenthal ArnonChief Executive OfficerDec 04, 2023 Sale$5.5623,831132,5002,019,217Dec 06, 2023, 06:30 PM
Kenkare-Mitra SaraPresident and Head of R&DDec 04, 2023 Sale$5.5612,51969,606329,016Dec 06, 2023, 06:30 PM
Polaris Venture Management Co. VI, L.L.C.10% OwnerSep 11, 2023 Sale$6.00500,0003,000,00010,853,817Sep 13, 2023, 04:33 PM
MCGUIRE TERRANCEDirectorSep 11, 2023 Sale$6.00500,0003,000,00010,853,817Sep 13, 2023, 04:29 PM
Rosenthal ArnonChief Executive OfficerSep 05, 2023 Sale$5.195,64729,3331,645,448Sep 06, 2023, 07:18 PM
Kenkare-Mitra SaraPresident and Head of R&DSep 05, 2023 Sale$5.196,21432,277177,935Sep 06, 2023, 07:17 PM
Romano GaryChief Medical OfficerSep 05, 2023 Sale$5.192,77114,39399,349Sep 06, 2023, 07:16 PM
GRASSO MARCChief Financial OfficerSep 05, 2023 Sale$5.191,1145,78632,247Sep 06, 2023, 07:14 PM
Kenkare-Mitra SaraPresident and Head of R&DJun 02, 2023 Sale$6.904,09228,250184,149Jun 05, 2023, 06:54 PM
GRASSO MARCChief Financial OfficerJun 02, 2023 Sale$6.901,0507,24933,361Jun 05, 2023, 06:52 PM
Romano GaryChief Medical OfficerJun 02, 2023 Sale$6.902,61718,067102,120Jun 05, 2023, 06:50 PM
Rosenthal ArnonChief Executive OfficerJun 02, 2023 Sale$6.905,25536,2791,651,095Jun 05, 2023, 06:48 PM
Rosenthal ArnonChief Executive OfficerMar 17, 2023 Sale$6.2215,18694,4281,656,350Mar 21, 2023, 08:35 PM
Romano GaryChief Medical OfficerMar 02, 2023 Sale$8.323,23826,933104,737Mar 03, 2023, 08:56 PM
Romano GaryChief Medical OfficerDec 02, 2022 Sale$8.712,14518,679107,975Mar 03, 2023, 08:56 PM
Kenkare-Mitra SaraPresident and Head of R&DMar 02, 2023 Sale$8.3210,12484,216188,241Mar 03, 2023, 08:53 PM
GRASSO MARCChief Financial OfficerMar 02, 2023 Sale$8.321,29110,73934,411Mar 03, 2023, 08:49 PM
Rosenthal ArnonChief Executive OfficerMar 02, 2023 Sale$8.325,84948,6511,628,546Mar 03, 2023, 08:47 PM
Yaffe KristineDirectorSep 10, 2021 Option Exercise$18.102,00036,2002,000Jan 31, 2023, 07:17 PM
Romano GaryChief Medical OfficerSep 02, 2022 Sale$10.622,17723,12090,073Sep 07, 2022, 04:17 PM
King RobertChief Development OfficerSep 02, 2022 Sale$10.621761,869529,295Sep 07, 2022, 04:15 PM
King RobertChief Development OfficerJun 02, 2022 Sale$8.711771,542529,471Jun 06, 2022, 04:52 PM
King RobertChief Development OfficerMar 01, 2022 Sale$15.572874,468528,404Mar 03, 2022, 05:41 PM
SULIMAN SHEHNAAZPresident and COODec 13, 2021 Option Exercise$17.2375,0001,292,250177,598Dec 14, 2021, 08:23 PM
SULIMAN SHEHNAAZPresident and COODec 10, 2021 Option Exercise$17.2375,0001,292,250177,598Dec 14, 2021, 08:23 PM
SULIMAN SHEHNAAZPresident and COODec 13, 2021 Sale$21.2475,0001,593,149113,496Dec 14, 2021, 08:23 PM
SULIMAN SHEHNAAZPresident and COODec 10, 2021 Sale$21.7675,0001,632,167111,472Dec 14, 2021, 08:23 PM
SULIMAN SHEHNAAZPresident and COODec 09, 2021 Option Exercise$17.2375,0001,292,250177,598Dec 10, 2021, 07:20 PM
SULIMAN SHEHNAAZPresident and COODec 08, 2021 Option Exercise$12.0975,000906,493177,598Dec 10, 2021, 07:20 PM
SULIMAN SHEHNAAZPresident and COODec 08, 2021 Sale$22.7975,0001,709,316141,087Dec 10, 2021, 07:20 PM
SULIMAN SHEHNAAZPresident and COODec 09, 2021 Sale$22.8275,0001,711,843105,241Dec 10, 2021, 07:20 PM
King RobertChief Development OfficerDec 01, 2021 Sale$20.092505,023528,691Dec 03, 2021, 05:08 PM
Rosenthal ArnonChief Executive OfficerNov 11, 2021 Sale$25.0055,0001,375,0001,972,875Nov 12, 2021, 06:36 PM
Rosenthal ArnonChief Executive OfficerNov 10, 2021 Sale$25.0055,0001,375,0002,027,875Nov 12, 2021, 06:36 PM
Rosenthal ArnonChief Executive OfficerNov 09, 2021 Sale$25.00100,0002,500,0002,082,875Nov 10, 2021, 07:07 PM
Rosenthal ArnonChief Executive OfficerNov 08, 2021 Sale$25.00100,0002,500,0002,137,875Nov 10, 2021, 07:07 PM
Rosenthal ArnonChief Executive OfficerNov 05, 2021 Sale$25.00100,0002,500,0002,192,875Nov 08, 2021, 06:39 PM
Rosenthal ArnonChief Executive OfficerNov 04, 2021 Sale$25.00100,0002,500,0002,247,875Nov 08, 2021, 06:39 PM
Rosenthal ArnonChief Executive OfficerSep 23, 2021 Sale$25.109,625241,5672,302,875Sep 23, 2021, 09:12 PM
Rosenthal ArnonChief Executive OfficerSep 22, 2021 Sale$25.33100,0002,533,1882,317,783Sep 23, 2021, 09:12 PM
Rosenthal ArnonChief Executive OfficerSep 20, 2021 Sale$25.80100,0002,580,3912,520,546Sep 22, 2021, 04:54 PM
Rosenthal ArnonChief Executive OfficerSep 21, 2021 Sale$26.11100,0002,611,4372,420,962Sep 22, 2021, 04:54 PM
Paul RobertChief Medical OfficerAug 09, 2021 Option Exercise$10.6922,950245,245257,269Aug 11, 2021, 06:23 PM
Paul RobertChief Medical OfficerAug 09, 2021 Sale$27.1822,950623,767234,619Aug 11, 2021, 06:23 PM
SCHELLER RICHARD HDirectorAug 05, 2021 Option Exercise$10.1456,260570,47656,260Aug 09, 2021, 06:13 PM
SCHELLER RICHARD HDirectorAug 05, 2021 Sale$27.6856,2601,557,3413,392Aug 09, 2021, 06:13 PM
SCHELLER RICHARD HDirectorJul 02, 2021 Sale$31.149,981310,8080Aug 09, 2021, 06:13 PM
Paul RobertChief Medical OfficerJul 07, 2021 Option Exercise$12.1529,749361,340264,068Jul 08, 2021, 06:24 PM
Paul RobertChief Medical OfficerJul 06, 2021 Option Exercise$17.1530,000514,500264,319Jul 08, 2021, 06:24 PM
Paul RobertChief Medical OfficerJul 06, 2021 Sale$37.3130,0001,119,167254,095Jul 08, 2021, 06:24 PM
Paul RobertChief Medical OfficerJul 07, 2021 Sale$38.7029,7491,151,237259,168Jul 08, 2021, 06:24 PM
Yu CalvinVice President, FinanceJul 02, 2021 Option Exercise$13.1360,840798,948187,526Jul 07, 2021, 07:38 PM
Yu CalvinVice President, FinanceJul 06, 2021 Option Exercise$13.033,33443,42980,020Jul 07, 2021, 07:38 PM
Yu CalvinVice President, FinanceJul 06, 2021 Sale$34.653,334115,52376,686Jul 07, 2021, 07:38 PM
Yu CalvinVice President, FinanceJul 02, 2021 Sale$32.74110,8403,629,07896,686Jul 07, 2021, 07:38 PM
King RobertChief Development OfficerJul 02, 2021 Option Exercise$9.1560,000549,000582,317Jul 07, 2021, 07:02 PM
King RobertChief Development OfficerJul 02, 2021 Sale$31.1460,0001,868,400522,317Jul 07, 2021, 07:02 PM
Paul RobertChief Medical OfficerJul 02, 2021 Option Exercise$17.1517,326297,141264,319Jul 06, 2021, 06:14 PM
Paul RobertChief Medical OfficerJul 02, 2021 Sale$31.1430,000934,200234,319Jul 06, 2021, 06:14 PM
Paul RobertChief Medical OfficerJul 01, 2021 Sale$22.2326,726594,124246,993Jul 06, 2021, 06:14 PM
Paul RobertChief Medical OfficerJun 08, 2021 Option Exercise$9.3919,175179,996292,894Jun 10, 2021, 05:24 PM
Paul RobertChief Medical OfficerJun 08, 2021 Sale$19.1819,175367,745276,719Jun 10, 2021, 05:24 PM
Yu CalvinVice President, FinanceJun 02, 2021 Sale$17.771,84432,768126,686Jun 03, 2021, 07:39 PM
Paul RobertChief Medical OfficerApr 07, 2021 Option Exercise$9.6022,300214,186236,019Apr 08, 2021, 08:18 PM
Paul RobertChief Medical OfficerApr 07, 2021 Sale$19.2022,300428,050213,764Apr 08, 2021, 08:18 PM
Paul RobertChief Medical OfficerMar 22, 2021 Option Exercise$8.1630,000244,800243,719Mar 24, 2021, 04:36 PM
Paul RobertChief Medical OfficerMar 23, 2021 Option Exercise$8.1613,800112,608227,519Mar 24, 2021, 04:36 PM
Paul RobertChief Medical OfficerMar 22, 2021 Sale$22.9830,000689,376219,229Mar 24, 2021, 04:36 PM
Paul RobertChief Medical OfficerMar 23, 2021 Sale$22.2113,800306,498213,719Mar 24, 2021, 04:36 PM
Paul RobertChief Medical OfficerMar 09, 2021 Option Exercise$8.3819,175160,592232,894Mar 10, 2021, 06:29 PM
Paul RobertChief Medical OfficerMar 09, 2021 Sale$18.1219,175347,405213,719Mar 10, 2021, 06:29 PM
Paul RobertChief Medical OfficerFeb 09, 2021 Option Exercise$8.3819,175160,594232,894Feb 11, 2021, 05:08 PM
Paul RobertChief Medical OfficerFeb 09, 2021 Sale$20.8119,175399,055213,719Feb 11, 2021, 05:08 PM
Paul RobertChief Medical OfficerJan 26, 2021 Option Exercise$8.4627,308231,082241,027Jan 27, 2021, 06:53 PM
Paul RobertChief Medical OfficerJan 25, 2021 Option Exercise$8.3030,000248,926243,719Jan 27, 2021, 06:53 PM
Paul RobertChief Medical OfficerJan 26, 2021 Sale$18.0027,308491,544213,719Jan 27, 2021, 06:53 PM
Paul RobertChief Medical OfficerJan 25, 2021 Sale$18.0130,000540,225213,719Jan 27, 2021, 06:53 PM
Paul RobertChief Medical OfficerJan 19, 2021 Option Exercise$8.3030,000248,924243,719Jan 21, 2021, 06:46 PM
Paul RobertChief Medical OfficerJan 20, 2021 Option Exercise$8.648,56774,031222,286Jan 21, 2021, 06:46 PM
Paul RobertChief Medical OfficerJan 20, 2021 Sale$18.008,567154,211213,719Jan 21, 2021, 06:46 PM
Paul RobertChief Medical OfficerJan 19, 2021 Sale$18.1230,000543,552213,719Jan 21, 2021, 06:46 PM
Paul RobertChief Medical OfficerJul 15, 2020 Sale$22.9610,000229,642214,097Jul 17, 2020, 04:43 PM
MCGUIRE TERRANCEDirectorJun 23, 2020 Sale$31.544,377138,06312,853,817Jun 25, 2020, 05:53 PM
Polaris Venture Management Co. VI, L.L.C.10% OwnerJun 23, 2020 Sale$31.544,377138,06312,853,817Jun 25, 2020, 05:47 PM
Paul RobertChief Medical OfficerJun 15, 2020 Sale$29.6110,000296,137227,628Jun 17, 2020, 04:21 PM
Yu CalvinVice President, FinanceJun 03, 2020 Sale$31.261,34341,981110,986Jun 05, 2020, 04:40 PM
Paul RobertChief Medical OfficerMay 15, 2020 Sale$27.0010,000270,026241,819May 19, 2020, 05:23 PM
King RobertChief Development OfficerMay 15, 2020 Sale$27.0015,000404,958488,952May 19, 2020, 05:23 PM
Paul RobertChief Medical OfficerApr 15, 2020 Sale$22.2710,000222,700243,719Apr 17, 2020, 05:12 PM
ORBIMED ADVISORS LLC10% OwnerApr 16, 2020 Sale$23.5362,1831,463,1665,955,674Apr 16, 2020, 08:23 PM
ORBIMED ADVISORS LLC10% OwnerApr 14, 2020 Sale$23.5223,231546,3936,002,771Apr 16, 2020, 08:23 PM
ORBIMED ADVISORS LLC10% OwnerApr 08, 2020 Sale$23.6582,6141,953,8216,238,574Apr 09, 2020, 05:30 PM
ORBIMED ADVISORS LLC10% OwnerApr 07, 2020 Sale$23.109,170211,8276,301,147Apr 09, 2020, 05:30 PM
ORBIMED ADVISORS LLC10% OwnerApr 09, 2020 Sale$23.79288,1016,853,9236,020,366Apr 09, 2020, 05:30 PM
ORBIMED ADVISORS LLC10% OwnerMar 31, 2020 Sale$24.50250,0006,125,0006,308,093Apr 02, 2020, 05:06 PM
ORBIMED ADVISORS LLC10% OwnerMar 25, 2020 Sale$24.6656,4111,391,0956,497,448Mar 25, 2020, 05:54 PM
ORBIMED ADVISORS LLC10% OwnerMar 24, 2020 Sale$24.4567,6441,653,8966,540,175Mar 25, 2020, 05:54 PM
ORBIMED ADVISORS LLC10% OwnerMar 23, 2020 Sale$26.0514,598380,2786,591,410Mar 25, 2020, 05:54 PM
Paul RobertChief Medical OfficerMar 13, 2020 Sale$22.9310,000229,286262,238Mar 17, 2020, 07:07 PM
ORBIMED ADVISORS LLC10% OwnerMar 02, 2020 Sale$26.001,874,20348,729,2786,602,467Mar 04, 2020, 12:00 AM
King RobertChief Development OfficerFeb 14, 2020 Sale$29.5615,000443,376502,649Feb 18, 2020, 05:00 PM
Paul RobertChief Medical OfficerFeb 14, 2020 Sale$29.5410,000295,390270,719Feb 18, 2020, 05:00 PM
Oney SabahChief Business OfficerFeb 07, 2020 Sale$35.0319,900697,097573,918Feb 11, 2020, 05:53 PM
Yu CalvinVice President, FinanceFeb 07, 2020 Option Exercise$9.5910,22598,088134,719Feb 10, 2020, 04:42 PM
Yu CalvinVice President, FinanceFeb 06, 2020 Option Exercise$8.951,82116,295127,115Feb 10, 2020, 04:42 PM
Yu CalvinVice President, FinanceFeb 07, 2020 Sale$35.0224,033841,636110,686Feb 10, 2020, 04:42 PM
Yu CalvinVice President, FinanceFeb 06, 2020 Sale$35.002,62191,735124,494Feb 10, 2020, 04:42 PM
Paul RobertChief Medical OfficerFeb 05, 2020 Option Exercise$8.1610,00081,600283,719Feb 07, 2020, 08:11 PM
Paul RobertChief Medical OfficerFeb 05, 2020 Sale$32.1010,000321,000273,719Feb 07, 2020, 08:11 PM
Oney SabahChief Business OfficerFeb 04, 2020 Option Exercise$8.1616,667136,003610,585Feb 06, 2020, 05:48 PM
Oney SabahChief Business OfficerFeb 06, 2020 Sale$35.001003,500593,818Feb 06, 2020, 05:48 PM
Oney SabahChief Business OfficerFeb 04, 2020 Sale$30.0016,667500,010593,918Feb 06, 2020, 05:48 PM
SCHELLER RICHARD HDirectorFeb 04, 2020 Sale$29.6710,000296,7009,981Feb 06, 2020, 05:19 PM
Yu CalvinVice President, FinanceFeb 04, 2020 Option Exercise$8.1613,541110,495188,835Feb 06, 2020, 05:18 PM
Yu CalvinVice President, FinanceFeb 04, 2020 Sale$30.0463,5411,908,772125,294Feb 06, 2020, 05:18 PM
Wehner David M.DirectorFeb 03, 2020 Buy$25.0020,000500,00044,621Feb 03, 2020, 06:19 PM
Paul RobertChief Medical OfficerJan 30, 2020 Option Exercise$8.168,00065,280281,719Feb 03, 2020, 06:14 PM
Paul RobertChief Medical OfficerJan 30, 2020 Sale$28.008,000224,000273,719Feb 03, 2020, 06:14 PM
Oney SabahChief Business OfficerJan 27, 2020 Option Exercise$8.1614,467118,051608,385Jan 27, 2020, 05:41 PM
Oney SabahChief Business OfficerJan 23, 2020 Option Exercise$8.162,20017,952596,118Jan 27, 2020, 05:41 PM
Oney SabahChief Business OfficerJan 27, 2020 Sale$25.0514,467362,398593,918Jan 27, 2020, 05:41 PM
Oney SabahChief Business OfficerJan 23, 2020 Sale$25.212,20055,462593,918Jan 27, 2020, 05:41 PM
Paul RobertChief Medical OfficerJan 23, 2020 Option Exercise$8.166,00048,960279,719Jan 27, 2020, 05:15 PM
Paul RobertChief Medical OfficerJan 23, 2020 Sale$24.326,000145,919274,318Jan 27, 2020, 05:15 PM
King RobertChief Development OfficerJan 22, 2020 Sale$22.01366507,317Jan 23, 2020, 04:48 PM
King RobertChief Development OfficerJan 21, 2020 Sale$22.0114,997330,084507,320Jan 23, 2020, 04:48 PM
Paul RobertChief Medical OfficerJan 15, 2020 Sale$18.6710,000186,700273,719Jan 17, 2020, 04:53 PM
ORBIMED ADVISORS LLC10% OwnerJan 09, 2020 Sale$19.50379,9977,409,9427,992,776Jan 13, 2020, 04:48 PM
ORBIMED ADVISORS LLC10% OwnerDec 26, 2019 Sale$18.6010,800200,8808,279,563Dec 26, 2019, 04:54 PM
ORBIMED ADVISORS LLC10% OwnerDec 24, 2019 Sale$19.5971,8001,406,5628,286,838Dec 26, 2019, 04:54 PM
ORBIMED ADVISORS LLC10% OwnerDec 23, 2019 Sale$19.8294,2851,868,7298,335,162Dec 26, 2019, 04:54 PM
ORBIMED ADVISORS LLC10% OwnerDec 20, 2019 Sale$19.66342,5006,733,5508,398,697Dec 26, 2019, 04:54 PM
ORBIMED ADVISORS LLC10% OwnerDec 17, 2019 Sale$18.52954,10017,669,9328,629,418Dec 19, 2019, 04:33 PM
Paul RobertChief Medical OfficerDec 13, 2019 Sale$20.0310,000200,300283,719Dec 17, 2019, 05:33 PM
Oney SabahChief Business OfficerDec 12, 2019 Option Exercise$8.166,81055,570600,728Dec 16, 2019, 08:13 PM
Oney SabahChief Business OfficerDec 12, 2019 Sale$20.136,810137,069593,918Dec 16, 2019, 08:13 PM
Oney SabahChief Business OfficerDec 10, 2019 Option Exercise$8.165004,080594,418Dec 12, 2019, 04:34 PM
Oney SabahChief Business OfficerDec 10, 2019 Sale$20.0150010,005593,918Dec 12, 2019, 04:34 PM
Oney SabahChief Business OfficerDec 06, 2019 Option Exercise$8.165,15642,073599,074Dec 09, 2019, 06:36 PM
Oney SabahChief Business OfficerDec 05, 2019 Option Exercise$8.161,50012,240595,418Dec 09, 2019, 06:36 PM
Oney SabahChief Business OfficerDec 09, 2019 Option Exercise$8.162,30018,768596,218Dec 09, 2019, 06:36 PM
Oney SabahChief Business OfficerDec 05, 2019 Sale$20.001,50030,000593,918Dec 09, 2019, 06:36 PM
Oney SabahChief Business OfficerDec 09, 2019 Sale$20.072,30046,161593,918Dec 09, 2019, 06:36 PM
Oney SabahChief Business OfficerDec 06, 2019 Sale$20.025,156103,223593,918Dec 09, 2019, 06:36 PM
Yu CalvinVice President, FinanceDec 03, 2019 Sale$18.311,31524,078175,294Dec 05, 2019, 04:25 PM
King RobertChief Development OfficerNov 15, 2019 Sale$15.927,500119,400522,317Nov 19, 2019, 04:47 PM
Paul RobertChief Medical OfficerNov 15, 2019 Sale$15.9310,000159,300293,719Nov 19, 2019, 04:45 PM
Paul RobertChief Medical OfficerAug 20, 2019 Option Exercise$8.169167,475324,635Nov 19, 2019, 04:42 PM
Paul RobertChief Medical OfficerAug 19, 2019 Option Exercise$8.161,0848,845324,803Nov 19, 2019, 04:42 PM
Paul RobertChief Medical OfficerAug 19, 2019 Sale$16.001,08417,344323,719Nov 19, 2019, 04:42 PM
Paul RobertChief Medical OfficerAug 20, 2019 Sale$16.0091614,656323,719Nov 19, 2019, 04:42 PM
Paul RobertChief Medical OfficerOct 15, 2019 Sale$14.6810,000146,800301,719Oct 17, 2019, 06:15 PM
Oney SabahChief Business OfficerSep 20, 2019 Option Exercise$8.164003,264594,318Sep 24, 2019, 06:34 PM
Oney SabahChief Business OfficerSep 20, 2019 Sale$20.004008,000593,918Sep 24, 2019, 06:34 PM
Paul RobertChief Medical OfficerSep 20, 2019 Option Exercise$8.164,00032,640315,719Sep 24, 2019, 06:33 PM
Paul RobertChief Medical OfficerSep 20, 2019 Sale$20.004,00080,000311,719Sep 24, 2019, 06:33 PM
Paul RobertChief Medical OfficerSep 16, 2019 Sale$19.0810,000190,800311,719Sep 18, 2019, 05:33 PM
King RobertChief Development OfficerAug 19, 2019 Sale$15.007,500112,500529,817Aug 21, 2019, 04:26 PM
Paul RobertChief Medical OfficerAug 20, 2019 Sale$16.0091614,656321,719Aug 21, 2019, 04:18 PM
Paul RobertChief Medical OfficerAug 19, 2019 Sale$16.001,08417,344322,635Aug 21, 2019, 04:18 PM
Paul RobertChief Medical OfficerAug 15, 2019 Sale$14.1910,000141,900323,719Aug 19, 2019, 05:19 PM
ORBIMED ADVISORS LLC10% OwnerAug 07, 2019 Sale$17.90650,00011,635,0009,272,225Aug 09, 2019, 06:41 PM
ORBIMED ADVISORS LLCDirectorFeb 11, 2019 Buy$19.00411,7007,822,30010,434,976Feb 11, 2019, 07:11 PM
GORDON CARL LDirectorFeb 11, 2019 Buy$19.00411,7007,822,30010,434,976Feb 11, 2019, 07:06 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
GRASSO MARCChief Financial Officer12/04/202325,431
Romano GaryChief Medical Officer12/04/202327,995
Rosenthal ArnonChief Executive Officer12/04/2023132,500
Kenkare-Mitra SaraPresident and Head of R&D12/04/202369,606
Polaris Venture Management Co. VI, L.L.C.10% Owner09/11/20233,000,000
MCGUIRE TERRANCEDirector09/11/20233,000,000
Rosenthal ArnonChief Executive Officer09/05/202329,333
Kenkare-Mitra SaraPresident and Head of R&D09/05/202332,277
Romano GaryChief Medical Officer09/05/202314,393
GRASSO MARCChief Financial Officer09/05/20235,786
Kenkare-Mitra SaraPresident and Head of R&D06/02/202328,250
GRASSO MARCChief Financial Officer06/02/20237,249
Romano GaryChief Medical Officer06/02/202318,067
Rosenthal ArnonChief Executive Officer06/02/202336,279
Rosenthal ArnonChief Executive Officer03/17/202394,428
Romano GaryChief Medical Officer03/02/202326,933
Romano GaryChief Medical Officer12/02/202218,679
Kenkare-Mitra SaraPresident and Head of R&D03/02/202384,216
GRASSO MARCChief Financial Officer03/02/202310,739
Rosenthal ArnonChief Executive Officer03/02/202348,651
Yaffe KristineDirector09/10/202136,200
Romano GaryChief Medical Officer09/02/202223,120
King RobertChief Development Officer09/02/20221,869
King RobertChief Development Officer06/02/20221,542
King RobertChief Development Officer03/01/20224,468
SULIMAN SHEHNAAZPresident and COO12/13/20211,292,250
SULIMAN SHEHNAAZPresident and COO12/10/20211,292,250
SULIMAN SHEHNAAZPresident and COO12/13/20211,593,149
SULIMAN SHEHNAAZPresident and COO12/10/20211,632,167
SULIMAN SHEHNAAZPresident and COO12/09/20211,292,250
SULIMAN SHEHNAAZPresident and COO12/08/2021906,493
SULIMAN SHEHNAAZPresident and COO12/08/20211,709,316
SULIMAN SHEHNAAZPresident and COO12/09/20211,711,843
King RobertChief Development Officer12/01/20215,023
Rosenthal ArnonChief Executive Officer11/11/20211,375,000
Rosenthal ArnonChief Executive Officer11/10/20211,375,000
Rosenthal ArnonChief Executive Officer11/09/20212,500,000
Rosenthal ArnonChief Executive Officer11/08/20212,500,000
Rosenthal ArnonChief Executive Officer11/05/20212,500,000
Rosenthal ArnonChief Executive Officer11/04/20212,500,000
Rosenthal ArnonChief Executive Officer09/23/2021241,567
Rosenthal ArnonChief Executive Officer09/22/20212,533,188
Rosenthal ArnonChief Executive Officer09/20/20212,580,391
Rosenthal ArnonChief Executive Officer09/21/20212,611,437
Paul RobertChief Medical Officer08/09/2021245,245
Paul RobertChief Medical Officer08/09/2021623,767
SCHELLER RICHARD HDirector08/05/2021570,476
SCHELLER RICHARD HDirector08/05/20211,557,341
SCHELLER RICHARD HDirector07/02/2021310,808
Paul RobertChief Medical Officer07/07/2021361,340
Paul RobertChief Medical Officer07/06/2021514,500
Paul RobertChief Medical Officer07/06/20211,119,167
Paul RobertChief Medical Officer07/07/20211,151,237
Yu CalvinVice President, Finance07/02/2021798,948
Yu CalvinVice President, Finance07/06/202143,429
Yu CalvinVice President, Finance07/06/2021115,523
Yu CalvinVice President, Finance07/02/20213,629,078
King RobertChief Development Officer07/02/2021549,000
King RobertChief Development Officer07/02/20211,868,400
Paul RobertChief Medical Officer07/02/2021297,141
Paul RobertChief Medical Officer07/02/2021934,200
Paul RobertChief Medical Officer07/01/2021594,124
Paul RobertChief Medical Officer06/08/2021179,996
Paul RobertChief Medical Officer06/08/2021367,745
Yu CalvinVice President, Finance06/02/202132,768
Paul RobertChief Medical Officer04/07/2021214,186
Paul RobertChief Medical Officer04/07/2021428,050
Paul RobertChief Medical Officer03/22/2021244,800
Paul RobertChief Medical Officer03/23/2021112,608
Paul RobertChief Medical Officer03/22/2021689,376
Paul RobertChief Medical Officer03/23/2021306,498
Paul RobertChief Medical Officer03/09/2021160,592
Paul RobertChief Medical Officer03/09/2021347,405
Paul RobertChief Medical Officer02/09/2021160,594
Paul RobertChief Medical Officer02/09/2021399,055
Paul RobertChief Medical Officer01/26/2021231,082
Paul RobertChief Medical Officer01/25/2021248,926
Paul RobertChief Medical Officer01/26/2021491,544
Paul RobertChief Medical Officer01/25/2021540,225
Paul RobertChief Medical Officer01/19/2021248,924
Paul RobertChief Medical Officer01/20/202174,031
Paul RobertChief Medical Officer01/20/2021154,211
Paul RobertChief Medical Officer01/19/2021543,552
Paul RobertChief Medical Officer07/15/2020229,642
MCGUIRE TERRANCEDirector06/23/2020138,063
Polaris Venture Management Co. VI, L.L.C.10% Owner06/23/2020138,063
Paul RobertChief Medical Officer06/15/2020296,137
Yu CalvinVice President, Finance06/03/202041,981
Paul RobertChief Medical Officer05/15/2020270,026
King RobertChief Development Officer05/15/2020404,958
Paul RobertChief Medical Officer04/15/2020222,700
ORBIMED ADVISORS LLC10% Owner04/16/20201,463,166
ORBIMED ADVISORS LLC10% Owner04/14/2020546,393
ORBIMED ADVISORS LLC10% Owner04/08/20201,953,821
ORBIMED ADVISORS LLC10% Owner04/07/2020211,827
ORBIMED ADVISORS LLC10% Owner04/09/20206,853,923
ORBIMED ADVISORS LLC10% Owner03/31/20206,125,000
ORBIMED ADVISORS LLC10% Owner03/25/20201,391,095
ORBIMED ADVISORS LLC10% Owner03/24/20201,653,896
ORBIMED ADVISORS LLC10% Owner03/23/2020380,278
Paul RobertChief Medical Officer03/13/2020229,286
ORBIMED ADVISORS LLC10% Owner03/02/202048,729,278
King RobertChief Development Officer02/14/2020443,376
Paul RobertChief Medical Officer02/14/2020295,390
Oney SabahChief Business Officer02/07/2020697,097
Yu CalvinVice President, Finance02/07/202098,088
Yu CalvinVice President, Finance02/06/202016,295
Yu CalvinVice President, Finance02/07/2020841,636
Yu CalvinVice President, Finance02/06/202091,735
Paul RobertChief Medical Officer02/05/202081,600
Paul RobertChief Medical Officer02/05/2020321,000
Oney SabahChief Business Officer02/04/2020136,003
Oney SabahChief Business Officer02/06/20203,500
Oney SabahChief Business Officer02/04/2020500,010
SCHELLER RICHARD HDirector02/04/2020296,700
Yu CalvinVice President, Finance02/04/2020110,495
Yu CalvinVice President, Finance02/04/20201,908,772
Wehner David M.Director02/03/2020500,000
Paul RobertChief Medical Officer01/30/202065,280
Paul RobertChief Medical Officer01/30/2020224,000
Oney SabahChief Business Officer01/27/2020118,051
Oney SabahChief Business Officer01/23/202017,952
Oney SabahChief Business Officer01/27/2020362,398
Oney SabahChief Business Officer01/23/202055,462
Paul RobertChief Medical Officer01/23/202048,960
Paul RobertChief Medical Officer01/23/2020145,919
King RobertChief Development Officer01/22/202066
King RobertChief Development Officer01/21/2020330,084
Paul RobertChief Medical Officer01/15/2020186,700
ORBIMED ADVISORS LLC10% Owner01/09/20207,409,942
ORBIMED ADVISORS LLC10% Owner12/26/2019200,880
ORBIMED ADVISORS LLC10% Owner12/24/20191,406,562
ORBIMED ADVISORS LLC10% Owner12/23/20191,868,729
ORBIMED ADVISORS LLC10% Owner12/20/20196,733,550
ORBIMED ADVISORS LLC10% Owner12/17/201917,669,932
Paul RobertChief Medical Officer12/13/2019200,300
Oney SabahChief Business Officer12/12/201955,570
Oney SabahChief Business Officer12/12/2019137,069
Oney SabahChief Business Officer12/10/20194,080
Oney SabahChief Business Officer12/10/201910,005
Oney SabahChief Business Officer12/06/201942,073
Oney SabahChief Business Officer12/05/201912,240
Oney SabahChief Business Officer12/09/201918,768
Oney SabahChief Business Officer12/05/201930,000
Oney SabahChief Business Officer12/09/201946,161
Oney SabahChief Business Officer12/06/2019103,223
Yu CalvinVice President, Finance12/03/201924,078
King RobertChief Development Officer11/15/2019119,400
Paul RobertChief Medical Officer11/15/2019159,300
Paul RobertChief Medical Officer08/20/20197,475
Paul RobertChief Medical Officer08/19/20198,845
Paul RobertChief Medical Officer08/19/201917,344
Paul RobertChief Medical Officer08/20/201914,656
Paul RobertChief Medical Officer10/15/2019146,800
Oney SabahChief Business Officer09/20/20193,264
Oney SabahChief Business Officer09/20/20198,000
Paul RobertChief Medical Officer09/20/201932,640
Paul RobertChief Medical Officer09/20/201980,000
Paul RobertChief Medical Officer09/16/2019190,800
King RobertChief Development Officer08/19/2019112,500
Paul RobertChief Medical Officer08/20/201914,656
Paul RobertChief Medical Officer08/19/201917,344
Paul RobertChief Medical Officer08/15/2019141,900
ORBIMED ADVISORS LLC10% Owner08/07/201911,635,000
ORBIMED ADVISORS LLCDirector02/11/20197,822,300
GORDON CARL LDirector02/11/20197,822,300
Load More Insider Transactions
FUNDS WITH A POSITION IN ALECTOR INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.8,068,5530.00164%4.37%Other
GEODE CAPITAL MANAGEMENT, LLC1,381,7860.00115%6.04%Other
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)1,067,8100.16%1.2%Other
BAKER BROS. ADVISORS LP964,8510.04%ExitedOther
RENAISSANCE TECHNOLOGIES LLC571,9830.00706%13.89%Other
D. E. SHAW & CO., INC.184,1470.00128%54.72%Other
AQR CAPITAL MANAGEMENT LLC65,6670.00099%2.93%Other
ALPS ADVISORS INC56,7900.00356%-8.15%Other
BALYASNY ASSET MANAGEMENT L.P.41,1360.00062%NewEvent Driven
BLACKSTONE INC.15,4290.00055%No changeOther
CHANGE IN SHARES OUTSTANDING FOR ALECTOR INC
STOCK BUYBACKS FOR ALECTOR INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.55%
1Q
12/31/2023
06/30/2023
0.99%
2Q
12/31/2023
03/31/2023
1.55%
3Q
12/31/2023
12/31/2022
1.97%
4Q
12/31/2023
09/30/2022
2.17%
5Q
12/31/2023
06/30/2022
2.19%
6Q
12/31/2023
03/31/2022
2.79%
7Q
12/31/2023
12/31/2021
15.52%
8Q
12/31/2023
09/30/2021
-0.99%
9Q
12/31/2023
06/30/2021
5.77%
10Q
12/31/2023
03/31/2021
6.31%
11Q
12/31/2023
12/31/2020
6.81%
12Q
12/31/2023
09/30/2020
7.14%
13Q
12/31/2023
06/30/2020
7.62%
14Q
12/31/2023
03/31/2020
12.79%
15Q
12/31/2023
12/31/2019
24.20%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.55%
1Q
06/30/2023
0.99%
2Q
03/31/2023
1.55%
3Q
12/31/2022
1.97%
4Q
09/30/2022
2.17%
5Q
06/30/2022
2.19%
6Q
03/31/2022
2.79%
7Q
12/31/2021
15.52%
8Q
09/30/2021
-0.99%
9Q
06/30/2021
5.77%
10Q
03/31/2021
6.31%
11Q
12/31/2020
6.81%
12Q
09/30/2020
7.14%
13Q
06/30/2020
7.62%
14Q
03/31/2020
12.79%
15Q
12/31/2019
24.20%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ALECTOR INC
LOADING...